Recursion CEO on $688M Exscientia acquisition: Hope to bring better medicines to patients sooner

Описание к видео Recursion CEO on $688M Exscientia acquisition: Hope to bring better medicines to patients sooner

Chris Gibson, Recursion co-founder and CEO, joins 'Squawk Box' to discuss the company's $688 million acquisition of Exscientia, the use of AI in drug discovery, and more.

Комментарии

Информация по комментариям в разработке